Cargando…

Unexpectedly High Efficacy of SARS-CoV-2 BNT162b2 Vaccine in Liver versus Kidney Transplant Recipients—Is It Related to Immunosuppression Only?

The BNT162b2 vaccine is reportedly effective in preventing severe disease in more than 90% of the general population, but its efficacy in transplant recipients remains controversial. We aimed to determine the immune response to the BNT162b2 vaccine in kidney (KTRs) and liver transplant recipients (L...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nazaruk, Paulina, Monticolo, Marta, Jędrzejczak, Anna Maria, Krata, Natalia, Moszczuk, Barbara, Sańko-Resmer, Joanna, Pilecki, Tomasz, Urbanowicz, Arkadiusz, Florczak, Michał, Pączek, Leszek, Foroncewicz, Bartosz, Mucha, Krzysztof
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8703477/ https://www.ncbi.nlm.nih.gov/pubmed/34960200 http://dx.doi.org/10.3390/vaccines9121454

Ejemplares similares

Hybrid Immunity Provides the Best COVID-19 Humoral Response in Immunocompromised Patients with or without SARS-CoV-2 Infection History
por: Nazaruk, Paulina, et al.
Publicado: (2023)

Peroxiredoxins as Markers of Oxidative Stress in IgA Nephropathy, Membranous Nephropathy and Lupus Nephritis
por: Krata, Natalia, et al.
Publicado: (2021)

Osteopontin—A Potential Biomarker for IgA Nephropathy: Machine Learning Application
por: Moszczuk, Barbara, et al.
Publicado: (2022)

NR3C1 Glucocorticoid Receptor Gene Polymorphisms Are Associated with Membranous and IgA Nephropathies
por: Pac, Michał, et al.
Publicado: (2021)

The Different Patterns of Over-the-Counter Nonsteroidal Anti-Inflammatory Drugs or Analgesics Use in Patients with Chronic Kidney Disease and the General Population
por: Mulka-Gierek, Maria, et al.
Publicado: (2022)

Lupus Nephritis and Dysbiosis
por: Monticolo, Marta, et al.
Publicado: (2023)

Oxidative Stress in Kidney Diseases: The Cause or the Consequence?
por: Krata, Natalia, et al.
Publicado: (2017)

Membranous Nephropathy: From Research Bench to Personalized Care
por: Moszczuk, Barbara, et al.
Publicado: (2021)

Organization of Post-Transplant Care and the 5-Year Outcomes of Kidney Transplantation
por: Szymańska, Agnieszka, et al.
Publicado: (2022)

Anti-HLA and Anti-MICA Antibodies in Liver Transplant Recipients: Effect on Long-Term Graft Survival
por: Ciszek, Michał, et al.
Publicado: (2013)

Reversal of stage 5 chronic kidney disease by aortic valve replacement in kidney transplant recipient: a case report
por: Hryniewiecka, E., et al.
Publicado: (2020)

Relapsing polychondritis in a liver transplant recipient: A case report
por: Mydlak, Anna, et al.
Publicado: (2017)

Circulating Osteoprotegerin in Chronic Kidney Disease and All-Cause Mortality
por: Kamińska, Joanna, et al.
Publicado: (2021)

Nonsteroidal Anti-Inflammatory Drugs and Analgesics Use by Kidney Transplant Recipients
por: Mulka-Gierek, Maria, et al.
Publicado: (2018)

Comparison of Post-Transplantation Lymphoproliferative Disorder Risk and Prognostic Factors between Kidney and Liver Transplant Recipients
por: Mucha, Krzysztof, et al.
Publicado: (2022)

Impact of Blood Pressure on Risk of Graft Failure or Death Among Patients After Kidney Transplantation in a 10-Year Observational Period: A Single-Center Retrospective Analysis
por: Pilecki, Tomasz, et al.
Publicado: (2023)

Influence of a Heterologous (ChAdOx1-nCoV-19/BNT162b2) or Homologous (BNT162b2/BNT162b2) Vaccination Regimen on the Antibody and T Cell Response to a Third Vaccination with BNT162b2
por: Reiter, Rieke, et al.
Publicado: (2022)

Age-Related Decline in Renal Blood Flow Could Be a Beneficial and Compensatory Mechanism
por: Czarkowska-Pączek, Bożena, et al.
Publicado: (2020)

Immunogenicity against the BNT162b2 mRNA COVID-19 Vaccine in Rheumatic Disease Patients Receiving Immunosuppressive Therapy
por: Sugihara, Koichi, et al.
Publicado: (2022)

Safety and antibody response of recipients who unexpectedly received undiluted prime dose of BNT162b2 COVID-19 vaccine in Taiwan
por: Sheng, Wang-Huei, et al.
Publicado: (2023)

Immunology and Donor-Specific Antibodies in Corneal Transplantation
por: Major, Joanna, et al.
Publicado: (2021)

Neutralizing Activity of BNT162b2-Elicited Serum
por: Liu, Yang, et al.
Publicado: (2021)

BNT162b2 vaccine for prevention of COVID-19
Publicado: (2021)

Boosting BNT162b2 vaccine efficacy in CLL
por: Bhat, Seema A., et al.
Publicado: (2022)

Erythema Multiforme after BNT162b2 Vaccination
por: Katayama, Sho, et al.
Publicado: (2022)

The effect of a third-dose BNT162b2 vaccine on anti-SARS-CoV-2 antibody levels in immunosuppressed patients
por: Saiag, Esther, et al.
Publicado: (2022)

The effect of methotrexate and targeted immunosuppression on humoral and cellular immune responses to the COVID-19 vaccine BNT162b2: a cohort study
por: Mahil, Satveer K, et al.
Publicado: (2021)

Pseudo-Anaphylactic Reactions to Pfizer BNT162b2 Vaccine: Report of 3 Cases of Anaphylaxis Post Pfizer BNT162b2 Vaccination
por: Lim, Xin Rong, et al.
Publicado: (2021)

Longitudinal Analysis of SARS-CoV-2-Specific Cellular and Humoral Immune Responses and Breakthrough Infection following BNT162b2/BNT162b2/BNT162b2 and ChAdOx1/ChAdOx1/BNT162b2 Vaccination: A Prospective Cohort in Naive Healthcare Workers
por: Ko, Geon Young, et al.
Publicado: (2023)

055 The impact of methotrexate and targeted immunosuppression on cellular and humoral immune responses to COVID-19 vaccine BNT162b2: a cohort study
por: Mahil, S.K., et al.
Publicado: (2021)

Omics are Getting Us Closer to Understanding IgA Nephropathy
por: Mucha, Krzysztof, et al.
Publicado: (2023)

BNT-162b1: Stevens-Johnson syndrome: case report
Publicado: (2021)

Waning Immunity after the BNT162b2 Vaccine in Israel
por: Goldberg, Yair, et al.
Publicado: (2021)

Myocarditis after BNT162b2 Vaccination in Israeli Adolescents
por: Mevorach, Dror, et al.
Publicado: (2022)

Acute interstitial nephritis after vaccination with BNT162b2
por: Rieckmann, Sonja, et al.
Publicado: (2022)

Effectiveness of BNT162b2 against COVID-19 in adolescents
por: Powell, Annabel A, et al.
Publicado: (2022)

Acute myocarditis following administration of BNT162b2 vaccine
por: Habib, Mhd Baraa, et al.
Publicado: (2021)

Beyond neutralization for BNT162b2 mRNA vaccination
por: Damani-Yokota, Payal, et al.
Publicado: (2021)

Myocarditis after BNT162b2 Vaccination in Israeli Adolescents
por: Witberg, Guy, et al.
Publicado: (2022)

Évaluation de l'immunogénicité après vaccination COVID-19 hétérologue ChAdOx1-nCoV19/BNT162b2 et homologue BNT162b2/BNT162b2– Cohorte ANRS0001S COV-POPART
por: Lachâtre, M., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_lll7i7ftvktvhhfe02lh9qgo75